Downregulation of STAT3/NF-κB potentiates gemcitabine activity in pancreatic cancer cells-Reference-Cited by-同舟云学术

Downregulation of STAT3/NF-κB potentiates gemcitabine activity in pancreatic cancer cells

Published:2016-05-25 Issue:2 Volume:56 Page:402-411
ISSN:0899-1987
Container-title:Molecular Carcinogenesis
language:en
Short-container-title:Mol. Carcinog.

Author:

Gong Jingjing¹,Muñoz Amanda R.²,Pingali Subramanya³,Payton-Stewart Florastina³,Chan Daniel E.⁴,Freeman James W.⁵⁶⁷,Ghosh Rita¹²⁶⁸,Kumar Addanki P.¹²⁶⁷⁸

Affiliation:

1. Department of Pharmacology; University of Texas Health Science Center; San Antonio Texas

2. Department of Urology; University of Texas Health Science Center; San Antonio Texas

3. Department of Chemistry; Xavier University of Louisiana; New Orleans Los Angeles

4. Division of Medical Oncology; University of Colorado; Aurora Colorado

5. Division of Medical Oncology; University of Texas Health Science Center; San Antonio Texas

6. Cancer Therapy and Research Center; University of Texas Health Science Center; San Antonio Texas

7. South Texas Veterans Health Care System; San Antonio Texas

8. Department of Molecular Medicine; University of Texas Health Science Center; San Antonio Texas

Publisher

Wiley

Subject

Cancer Research,Molecular Biology

Reference41 articles.

1. Cancer statistics, 2015;Siegel;CA Cancer J Clin,2015

2. Cellular pharmacology of gemcitabine;Mini;Ann Oncol,2006

3. Gemcitabine chemoresistance and molecular markers associated with gemcitabine transport and metabolism in human pancreatic cancer cells;Nakano;Br J Cancer,2007

4. The MUC4 mucin mediates gemcitabine resistance of human pancreatic cancer cells via the concentrative nucleoside transporter family;Skrypek;Oncogene,2013

5. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer;Conroy;N Engl J Med,2011

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BP1003 Decreases STAT3 Expression and Its Pro-Tumorigenic Functions in Solid Tumors and the Tumor Microenvironment;Biomedicines;2024-08-20

2. Tumor-derived exosome PPP3CB induce gemcitabine resistance by regulating miR-298/STAT3 in pancreatic cancer;Heliyon;2024-08

3. Gemcitabine‐Loaded Injectable Hydrogel for Localized Breast Cancer Immunotherapy;Advanced Functional Materials;2024-07-06

4. Inhibitory effect of liriopesides B in combination with gemcitabine on human pancreatic cancer cells;Bioorganic Chemistry;2024-01

5. Cancer Immunotherapy Using Bioengineered Micro/Nano Structured Hydrogels;Advanced Healthcare Materials;2023-09